- Home
- FEMY vs CMBM Comparison
FEMY vs CMBM Comparison
Compare FEMY & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- CMBM
- Stock Information
- Founded
- FEMY 2004
- CMBM 2011
- Country
- FEMY United States
- CMBM United States
- Employees
- FEMY 71
- CMBM N/A
- Industry
- FEMY Medical/Dental Instruments
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- FEMY Health Care
- CMBM Technology
- Exchange
- FEMY Nasdaq
- CMBM Nasdaq
- Market Cap
- FEMY 23.1M
- CMBM 26.5M
- IPO Year
- FEMY 2021
- CMBM 2019
- Fundamental
- Price
- FEMY $0.71
- CMBM $0.70
- Analyst Decision
- FEMY Strong Buy
- CMBM Buy
- Analyst Count
- FEMY 3
- CMBM 1
- Target Price
- FEMY $7.33
- CMBM $3.00
- AVG Volume (30 Days)
- FEMY 238.0K
- CMBM 512.6K
- Earning Date
- FEMY 08-08-2025
- CMBM 08-26-2025
- Dividend Yield
- FEMY N/A
- CMBM N/A
- EPS Growth
- FEMY N/A
- CMBM N/A
- EPS
- FEMY N/A
- CMBM N/A
- Revenue
- FEMY $1,887,016.00
- CMBM $172,215,000.00
- Revenue This Year
- FEMY $283.83
- CMBM N/A
- Revenue Next Year
- FEMY $161.03
- CMBM $17.73
- P/E Ratio
- FEMY N/A
- CMBM N/A
- Revenue Growth
- FEMY 98.61
- CMBM N/A
- 52 Week Low
- FEMY $0.69
- CMBM $0.23
- 52 Week High
- FEMY $1.80
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- FEMY 34.99
- CMBM 45.40
- Support Level
- FEMY $0.72
- CMBM $0.70
- Resistance Level
- FEMY $1.00
- CMBM $0.80
- Average True Range (ATR)
- FEMY 0.06
- CMBM 0.12
- MACD
- FEMY -0.01
- CMBM -0.04
- Stochastic Oscillator
- FEMY 0.89
- CMBM 5.34
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.